Mapping the Binding of GluN2B-Selective N-Methyl-D-aspartate Receptor Negative Allosteric Modulators

被引:40
|
作者
Burger, Pieter B. [1 ]
Yuan, Hongjie [2 ]
Karakas, Erkan [3 ]
Geballe, Matthew [1 ]
Furukawa, Hiro [3 ]
Liotta, Dennis C. [1 ]
Snyder, James P. [1 ]
Traynelis, Stephen F. [2 ]
机构
[1] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Pharmacol, Atlanta, GA USA
[3] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
基金
美国国家卫生研究院;
关键词
AMINO-TERMINAL DOMAIN; ANTI-ISCHEMIC AGENTS; NMDA RECEPTOR; NR2B SUBUNIT; ANTAGONIST PROPERTIES; PI INTERACTIONS; IFENPRODIL; PROTEIN; SUBTYPE; MECHANISMS;
D O I
10.1124/mol.112.078568
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have used recent structural advances in our understanding of the N-methyl-D-aspartate (NMDA) receptor amino terminal domain to explore the binding mode of multiple diaryl GluN2B-selective negative allosteric modulators at the interface between the GluN1 and GluN2B amino-terminal domains. We found that interaction of the A ring within the binding pocket seems largely invariant for a variety of structurally distinct ligands. In addition, a range of structurally diverse linkers between the two aryl rings can be accommodated by the binding site, providing a potential opportunity to tune interactions with the ligand binding pocket via changes in hydrogen bond donors, acceptors, as well as stereochemistry. The most diversity in atomic interactions between protein and ligand occur in the B ring, with functional groups that contain electron donors and acceptors providing additional atomic contacts within the pocket. A cluster of residues distant to the binding site also control ligand potency, the degree of inhibition, and show ligand-induced increases in motion during molecular dynamics simulations. Mutations at some of these residues seem to distinguish between structurally distinct ligands and raise the possibility that GluN2B-selective ligands can be divided into multiple classes. These results should help facilitate the development of well tolerated GluN2B subunit-selective antagonists.
引用
收藏
页码:344 / 359
页数:16
相关论文
共 50 条
  • [21] Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl-D-aspartate Receptors
    Strong, Katie L.
    Epplin, Matthew P.
    Ogden, Kevin K.
    Burger, Pieter B.
    Kaiser, Thomas M.
    Wilding, Timothy J.
    Kusumoto, Hiro
    Camp, Chad R.
    Shaulsky, Gil
    Bhattacharya, Subhrajit
    Perszyk, Riley E.
    Menaldino, David S.
    McDaniel, Miranda J.
    Zhang, Jing
    Phuong Le
    Banke, Tue G.
    Hansen, Kasper B.
    Huettner, James E.
    Liotta, Dennis C.
    Traynelis, Stephen F.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (01): : 79 - 98
  • [22] Identification of AICP as a GluN2C-Selective N-Methyl-D-Aspartate Receptor Superagonist at the GluN1 Glycine Site
    Jessen, Maja
    Frederiksen, Kristen
    Yi, Feng
    Clausen, Rasmus P.
    Hansen, Kasper B.
    Brauner-Osborne, Hans
    Kilburn, Paul
    Damholt, Anders
    MOLECULAR PHARMACOLOGY, 2017, 92 (02) : 151 - 161
  • [23] Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
    Jesse E. Hanson
    Hongjie Yuan
    Riley E. Perszyk
    Tue G. Banke
    Hao Xing
    Ming-Chi Tsai
    Frank S. Menniti
    Stephen F. Traynelis
    Neuropsychopharmacology, 2024, 49 : 51 - 66
  • [24] THE DISCOVERY OF NEW CHEMICAL MODULATORS OF THE N-METHYL-D-ASPARTATE RECEPTOR
    KOZIKOWSKI, AP
    TUECKMANTEL, W
    MALONEYHUSS, K
    CALCIUM, MEMBRANES, AGING, AND ALZHEIMERS DISEASE, 1989, 568 : 159 - 165
  • [25] Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
    Hanson, Jesse E.
    Yuan, Hongjie
    Perszyk, Riley E.
    Banke, Tue G.
    Xing, Hao
    Tsai, Ming-Chi
    Menniti, Frank S.
    Traynelis, Stephen F.
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (01) : 51 - 66
  • [26] THE DISCOVERY OF NEW CHEMICAL MODULATORS OF THE N-METHYL-D-ASPARTATE RECEPTOR
    KOZIKOWSKI, AP
    TUECKMANTEL, W
    MALONEYHUSS, K
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1989, 568 : 159 - 165
  • [27] Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators
    Dong, Chao
    Hashimoto, Kenji
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2015, 13 (03) : 328 - 329
  • [28] Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists
    Tahirovic, Yesim A.
    Geballe, Matthew
    Gruszecka-Kowalik, Ewa
    Myers, Scott J.
    Lyuboslavsky, Polina
    Le, Phuong
    French, Adam
    Irier, Hasan
    Choi, Woo-baeg
    Easterling, Keith
    Yuan, Hongjie
    Wilson, Lawrence J.
    Kotloski, Robert
    McNamara, James O.
    Dingledine, Raymond
    Liotta, Dennis C.
    Traynelis, Stephen F.
    Snyder, James P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) : 5506 - 5521
  • [29] Neuroactive Steroid N-Methyl-D-aspartate Receptor Positive Allosteric Modulators: Synthesis, SAR, and Pharmacological Activity
    La, Daniel S.
    Salituro, Francesco G.
    Botella, Gabriel Martinez
    Griffin, Andrew M.
    Bai, Zhu
    Ackley, Michael A.
    Dai, Jing
    Doherty, James J.
    Harrison, Boyd L.
    Hoffmann, Ethan C.
    Kazdoba, Tatiana M.
    Lewis, Michael C.
    Quirk, Michael C.
    Robichaud, Albert J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (16) : 7526 - 7542
  • [30] Involvement of the GluN2A and GluN2B Subunits in Synaptic and Extrasynaptic N-methyl-D-aspartate Receptor Function and Neuronal Excitotoxicity
    Zhou, Xianju
    Ding, Qi
    Chen, Zhuoyou
    Yun, Huifang
    Wang, Hongbing
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (33) : 24151 - 24159